Findings reveal significant mutations in chikungunya virus, suggesting implications for immunity and vaccine design.
These findings indicate that a relevant number of mutations have accumulated in CHIKV circulating in Brazil and worldwide, with potential to impact immunological control of the virus and its replication and pathogenesis.
No takes yet. Share an insight, caveat, or question.
Fogaça et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: